Form 4: Bionano Genomics COO Reports Share Withholding for Tax Obligations After Stock Split

Mark Oldakowski, COO of Bionano Genomics, reports the withholding of 20 common shares to cover tax obligations related to vested RSUs, following a 1-for-60 stock split.

Summary

• On February 15, 2025, Bionano Genomics withheld 20 shares of common stock from Chief Operating Officer Mark Oldakowski to cover tax obligations related to vested Restricted Stock Units (RSUs).
• These RSUs vested on February 15, 2025, and were initially granted on February 15, 2023.
• The withholding occurred because the shares were not issued to satisfy Oldakowski's tax obligations upon the RSU settlement.
• The price per share for the withholding was $5.73.
• On January 24, 2025, Bionano Genomics executed a 1-for-60 stock split, which resulted in Oldakowski owning 60,262 fewer shares.
• Following the reported transaction, Oldakowski beneficially owns 1,001 shares.

Sentiment

Score: 5

Explanation: This is a routine filing related to standard compensation practices and a previously announced stock split, so it has a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing reflects standard practices related to equity compensation and tax obligations.

Stakeholder Impact

• The stock split may affect shareholders' perception of the stock's price, although the overall value remains the same.

Key Dates

Keywords

Bionano Genomics, BNGO, Form 4, Mark Oldakowski, Chief Operating Officer, Stock withholding, RSU, Stock split, Beneficial ownership, Tax obligations